The substance drug abuse market was valued at USD 8.06 Billion in 2024, driven by the rising incidence of substance abuse across the 8 major markets. The market is expected to grow at a CAGR of 5.10% during the forecast period of 2025-2034, with the values likely to reach USD 13.25 Billion by 2034.
Base Year
Historical Year
Forecast Year
The market for substance drug abuse is driven by the rising incidences of substance abuse, propelled by stress and anxiety, peer pressure, and mental health issues among the general public.
The rising introduction of grant fund opportunities directed at promoting the development of solutions that enhance the treatment, diagnosis, or monitoring of people affected by substance use disorder and addiction is expected to boost market growth in the coming years.
The increasing use of mobile health apps to manage drug addiction issues is a significant market trend.
Value in USD Billion
2025-2034
Substance Drug Abuse Market Outlook
*this image is indicative*
Substance abuse or drug abuse refers to the excessive use of psychoactive drugs like pain medications, alcohol, or illegal drugs which can result in emotional, physical, and social harm to an individual. Alcohol is reported as the most commonly used drug by Americans, followed by tobacco and marijuana. In the United States, 1 in 4 people over the age of 12 admitted to the use of illicit drugs. The market for substance drug abuse is driven by the rising incidences of substance abuse, propelled by stress and anxiety, peer pressure, and mental health issues among the general public. The rise in government policies and initiatives that work towards reducing drug abuse and raising awareness about the dangers of addiction are expected to fuel market growth. Moreover, the expansion of treatment options, growth in telemedicine services, and the increasing adoption of digital health technologies are anticipated to shape the market dynamics.
Increasing Incidence of Substance Abuse is Driving Market Growth
Drug and substance abuse poses a major problem in the United States. According to the recent National Survey on Drug Use, 70 million Americans accounting for 25% of the population admitted to using illicit drugs such as cocaine, heroin, and methamphetamines. The survey also revealed that 48.7 million individuals in the United States struggle with substance abuse. The rising incidence of substance abuse, driven by factors such as stress, peer pressure, and mental health issues, is contributing to the market growth.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Treatment Type:
Market Breakup by Route of Administration:
Market Breakup by End User:
Market Breakup by Region:
Treatment Segment is Anticipated to Witness Substantial Growth
The market segmentation based on treatment includes drugs (methadone, buprenorphine, naltrexone, and others), as well as counseling and behavioral therapy, among others. The drug segment helps in managing withdrawal symptoms and cravings. Methadone is commonly used to treat opioid addiction and is also included in government-supported treatment programs due to its established efficacy. Counseling and behavioral therapies also play a significant role in addiction treatment. The growing demand for virtual counseling services, particularly through telehealth platforms, is poised to aid the growth of the treatment segment in the forecast period.
The market segmentation by region includes the United States, EU-4 (Germany, France, Italy, Spain), the United Kingdom, Japan, and India. The United States dominates the market share owing to the increased legalization of cannabis and the growing public awareness about mental health issues. Increased government initiatives such as the establishment of the Substance Abuse and Mental Health Services Administration (SAMHSA), an agency that operates within the U.S. Department of Health and Human Services, work towards enhancing behavioral health in the country including services that improve the accessibility of substance use and mental disorder information. Additionally, the expansion of telehealth services and the rising emphasis on prescription drug abuse are likely to support the market growth.
The key features of the market report comprise patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:
Pfizer, headquartered in New York, United States, plays a significant role in the growth of the market. Pfizer manufactures Naloxone Hydrochloride Injection, USP, a pure opioid antagonist that can prevent or reverse the effects of opioids such as sedation, hypotension, and respiratory depression.
Mallinckrodt Pharmaceuticals, based in Staines-upon-Thames, United Kingdom, is a leading manufacturer of generic medications, specialty drugs, and imaging agents. The company manufactures methadone products including Methadone hydrochloride tablets that are prescribed to manage opioid addiction in maintenance or detoxification programs.
United Kingdom-based Rosemont Pharmaceuticals has a prominent presence in the market, known for its novel-delivery, patient-centered medications. The company specializes in the manufacturing of oral liquid medicine across a range of therapeutic areas including medications for substance abuse treatment like methadone and buprenorphine. Methadone Hydrochloride SF Oral Solution is one of the key medications of Rosemont indicated for the treatment of drug addiction or as a narcotic abstinence syndrome suppressant.
Spectrum Chemical is one of the leading players in the market, recognized as a global provider of quality chemicals and laboratory equipment, among others. The company sells Methadone Hydrochloride (CII), USP which is a synthetic opioid with analgesic activity.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Taj Pharmaceuticals Limited, VistaPharm LLC, Teva Pharmaceuticals Inc., Hikma Pharmaceutical PLC, Braeburn Inc., and Atlas Medical GmbH.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment Type |
|
| Breakup by Route of Administration |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share